04/04/2026
For years, menopause hormone therapy (MHT) has been shaped by fear.
That fear largely came from the Women’s Health Initiative (WHI) study (2002) - which led to a global drop in prescribing and the addition of an FDA “black box” warning in 2003, highlighting risks like breast cancer, cardiovascular disease, and dementia.
👉 But here’s what we’ve learned:
The original messaging was overly broad. Many women in the study were older (average age ~63) - not typical of when treatment is started and the hormone types don’t reflect modern practice
Over the past 20+ years, evidence has clarified:
✔️ Timing matters -> starting closer to menopause changes the risk profile
✔️ Type and delivery matter -> transdermal vs oral, different progesterones
✔️ Risk is individual -> not one-size-fits-all
The FDA has now REMOVED the boxed warning requirement.
Why? Because it didn’t reflect current evidence or practice and likely contributed to years of under-treatment and unnecessary suffering.
⚖️ What this means now
We move from:
❌ Fear-based prescribing
➡️ To confident, informed, individualised care
Because menopause care isn’t about avoiding risk at all costs,
it’s about balancing risk with quality of life
For too long, many women have been:
Dismissed
Misinformed
Left to cope
And suffered unnecessarily
🇳🇿 Want to understand your options?
If you’ve ever been told hormones “aren’t safe”-
or felt unsure about what’s right for you…
I’ve created a NZ-developed course/resource, grounded in evidence and clinical experience.
Designed to help you:
✔️ Understand your options
✔️ Make informed decisions
✔️ Feel confident
✨ Check out my course/resource (link in bio)
🎁 Easter offer:
DM/or comment EASTER for a 50% off code (limited available) (RRP $140)
🌟⭐️✨
“I wish I had know this earlier”
“This gave me confidence to ask”
“Tears… because things now make sense”
The time is now.
I don’t hear women say “I started too early” but I hear frequently “why did I wait?”